title: Two pathways for biliary copper excretion in the rat. The role of glutathione.
abstract: To evaluate the role of glutathione in biliary copper excretion, we studied this process in control Wistar rats and in mutant Wistar rats (GY rats), in which the secretion of glutathione into bile is deficient. For comparison, biliary zinc excretion was determined simultaneously. In spite of the markedly reduced bile flow (-45%) in GY rats, biliary output rates of endogenous copper were virtually identical in GY and control rats. In contrast, zinc output was drastically reduced in GY rats compared to controls (-80%). Biliary excretion patterns after intravenous administration of copper, in doses ranging from 65 to 2265 nmol/100 g/body wt, showed a distinct rapid and slow phase in control rats. In GY rats, on the other hand, the rapid phase in copper excretion was absent but the slow phase appeared to be unaffected. Pretreatment of rats with diethylmaleate to deplete hepatic and biliary glutathione abolished the rapid phase of copper excretion in control rats, while the slow phase remained unaffected. No significant effect of diethylmaleate on the hepatic handling of exogenous copper was observed in GY rats. The maximal capacity of the slow copper excretion pathway was 40-45 nmol/hr/100 g body wt, both in control and GY rats; the capacity of rapid excretion pathway depended on the administered copper load. Intravenous injection of copper induced the biliary excretion of a substantial amount of zinc in control rats, but not in GY rats. These results indicate the existence of at least two distinct biliary excretory pathways for copper in the rat, i.e. a slow and a rapid pathway, with a glutathione dependency of the latter only. The basal excretion of (endogenous) copper, in contrast to that of zinc, can proceed independently of glutathione excretion. However, glutathione appears to be involved in the rapid secretion of excess copper.
authors.affiliation: Department of Pediatrics, University of Groningen, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Houwen
authors.forename: M
authors.initials: M
authors.lastname: Dijkstra
authors.forename: F
authors.initials: F
authors.lastname: Kuipers
authors.forename: E P
authors.initials: EP
authors.lastname: Smit
authors.forename: R
authors.initials: R
authors.lastname: Havinga
authors.forename: R J
authors.initials: RJ
authors.lastname: Vonk
mesh_terms: D000818:Animals; D001646:Bile / Q000187:drug effects / Q000378:metabolism*; D003300:Copper / Q000378:metabolism*; D005978:Glutathione / Q000502:physiology*; D006933:Hyperbilirubinemia, Hereditary / Q000378:metabolism; D008298:Maleates / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011922:Rats, Mutant Strains; D015032:Zinc / Q000378:metabolism
chemical_list: D008298:Maleates; D003300:Copper; C014476:diethyl maleate; D005978:Glutathione; D015032:Zinc